Nextech Invest Ag Tango Therapeutics, Inc. Transaction History
Nextech Invest Ag
- $536 Million
- Q4 2024
A detailed history of Nextech Invest Ag transactions in Tango Therapeutics, Inc. stock. As of the latest transaction made, Nextech Invest Ag holds 5,533,980 shares of TNGX stock, worth $26.6 Million. This represents 3.19% of its overall portfolio holdings.
Number of Shares
5,533,980
Previous 5,533,980
-0.0%
Holding current value
$26.6 Million
Previous $42.6 Million
59.87%
% of portfolio
3.19%
Previous 6.95%
Shares
1 transactions
Others Institutions Holding TNGX
# of Institutions
123Shares Held
98MCall Options Held
1.1KPut Options Held
0-
Trv Gp Iv, LLC Boston, MA16.9MShares$80.9 Million88.92% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA10.7MShares$51.5 Million3.54% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA10.6MShares$51 Million1.14% of portfolio
-
Nextech Invest, Ltd. Zurich, V85.53MShares$26.6 Million1.76% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4.61MShares$22.1 Million0.04% of portfolio
About Tango Therapeutics, Inc.
- Ticker TNGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 88,067,296
- Market Cap $423M
- Description
- Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...